FIELD: medicine.
SUBSTANCE: invention relates to medicine and concerns a method for the treatment of polycystic ovary syndrome associated with metabolic syndrome. The essence of the method is that the following drugs are prescribed orally: myo-inositol at a dose of 2000-3000 mg, as well as D-chiro-inositol at a dose of 400-600 mg per day in combination with oral administration of sulodexide at a dose of 500-750 lipoprotein lipase units per day for at least 6 months.
EFFECT: use of the method makes it possible to effectively treat PCOS associated with metabolic syndrome.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF CORRECTING MENSTRUAL IRREGULARITIES IN WOMEN WITH METABOLIC SYNDROME | 2022 |
|
RU2813333C1 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING POLYCYSTIC OVARY SYNDROME | 2020 |
|
RU2757220C1 |
| METHOD FOR TREATING CHRONIC ANOVULATION AND PREVENTING SYNDROME OF OVARIAN HYPERSTIMULATION | 1999 |
|
RU2201225C2 |
| METHOD FOR INTEGRATED TREATMENT OF OBESITY ACCOMPANYING POLYCYSTIC OVARY SYNDROME | 2014 |
|
RU2564439C1 |
| METHOD FOR TREATMENT OF POLYCYSTIC OVARY SYNDROME | 2017 |
|
RU2665969C1 |
| METHOD FOR PREDICTION OF CLINICAL EFFECTIVENESS OF METFORMIN AND/OR WEIGHT-LOSS THERAPY IN PATIENTS WITH POLYCYSTIC OVARIAN SYNDROME | 2010 |
|
RU2427842C1 |
| METHOD OF DERMATOSIS DEVELOPMENT PREDICTION IN WOMEN WITH SCLEROPOLYCYSTIC OVARIAN SYNDROME (SPCO) | 2008 |
|
RU2367954C1 |
| METHOD FOR INTEGRATED TREATMENT OF POLYCYSTIC OVARIAN SYNDROME AND OBESITY | 2014 |
|
RU2566291C1 |
| METHOD OF DIAGNOSTICS OF MENSTRUAL DYSFUNCTION AGAINST BACKGROUND OF POLYCYSTIC OVARIAN SYNDROME BY IMMATURE GIRLS | 2013 |
|
RU2535096C1 |
| METHOD OF TREATING POLYCYSTIC OVARY SYNDROME IN FEMALES SUFFERING AFFECTIVE AND VEGETATIVE DISORDERS | 2010 |
|
RU2448695C2 |
